These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9551675)

  • 1. Alpha-glutathione transferases in HCV-related chronic hepatitis: a new predictive index of response to interferon therapy?
    Loguercio C; Caporaso N; Tuccillo C; Morisco F; Del Vecchio Blanco G; Del Vecchio Blanco C
    J Hepatol; 1998 Mar; 28(3):390-5. PubMed ID: 9551675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of alpha-glutathione S-transferase in the monitoring of hemodialysis patients with hepatitis C virus infection undergoing high-dose interferon-alpha-2b therapy.
    Boran M; Cetin S
    Nephron; 1999; 82(1):22-6. PubMed ID: 10224480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood serum glutathione alpha s-transferase (alpha GST) activity during antiviral therapy in patients with chronic hepatitis C.
    Mazur W; Gonciarz M; Kajdy M; Mazurek U; Jurzak M; Wilczok T; Gonciarz Z
    Med Sci Monit; 2003 Aug; 9 Suppl 3():44-8. PubMed ID: 15156612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of response during interferon alfa 2b therapy in chronic hepatitis C patients using viral and biochemical characteristics: a comparison.
    Tong MJ; Blatt LM; McHutchison JG; Co RL; Conrad A
    Hepatology; 1997 Dec; 26(6):1640-5. PubMed ID: 9398010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antioxidant supplementation attenuates oxidative stress in chronic hepatitis C patients.
    Farias MS; Budni P; Ribeiro CM; Parisotto EB; Santos CE; Dias JF; Dalmarco EM; Fröde TS; Pedrosa RC; Wilhelm Filho D
    Gastroenterol Hepatol; 2012; 35(6):386-94. PubMed ID: 22608494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical, virologic and pathologic significance of elevated serum gamma-glutamyl transpeptidase in patients with chronic hepatitis C.
    Hwang SJ; Luo JC; Lai CR; Chu CW; Tsay SH; Lu CL; Wu JC; Chang FY; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Jul; 63(7):527-35. PubMed ID: 10934805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon treatment in patients with chronic hepatitis C with normal alanine-aminotransferase activity.
    Yagura M; Murai S; Kojima H; Tokita H; Kamitsukasa H; Harada H
    Hepatogastroenterology; 1999; 46(26):1094-9. PubMed ID: 10370673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Permanent response to alpha-interferon therapy in chronic hepatitis C is preceded by rapid clearance of HCV-RNA from serum.
    Ampurdanés S; Olmedo E; Maluenda MD; Forns X; López-Labrador FX; Costa J; Sánchez-Tapias JM; de Anta MT; Rodés J
    J Hepatol; 1996 Dec; 25(6):827-32. PubMed ID: 9007709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early prediction of response in interferon monotherapy and in interferon-ribavirin combination therapy for chronic hepatitis C: HCV RNA at 4 weeks versus ALT.
    Brouwer JT; Hansen BE; Niesters HG; Schalm SW
    J Hepatol; 1999 Feb; 30(2):192-8. PubMed ID: 10068095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of supplementation with the antioxidant flavonoid, silymarin, in chronic hepatitis C patients treated with peg-interferon + ribavirin. A placebo-controlled double blind study].
    Pár A; Roth E; Miseta A; Hegedüs G; Pár G; Hunyady B; Vincze A
    Orv Hetil; 2009 Jan; 150(2):73-9. PubMed ID: 19103558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gamma-glutamyl transferase (GGT) as an independent predictive factor of sustained virologic response in patients with hepatitis C treated with interferon-alpha and ribavirin.
    Villela-Nogueira CA; Perez RM; de Segadas Soares JA; Coelho HS
    J Clin Gastroenterol; 2005 Sep; 39(8):728-30. PubMed ID: 16082285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased levels of gammaGT suggest the presence of bile duct lesions in patients with chronic hepatitis C: absence of influence of HCV genotype, HCV-RNA serum levels, and HGV infection on this histological damage.
    Giannini E; Botta F; Fasoli A; Romagnoli P; Mastracci L; Ceppa P; Comino I; Pasini A; Risso D; Testa R
    Dig Dis Sci; 2001 Mar; 46(3):524-9. PubMed ID: 11318526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of plasma alpha-glutathione S-transferases in patients with HCV-related chronic infection: its significance and possible clinical relevance.
    Loguercio C; Tuccillo C; Caporaso N; Del Vecchio Blanco G; Morisco F; Guerriero C; di Santolo SS; Valenza LM; Del Vecchio Blanco C
    Liver; 1998 Jun; 18(3):166-72. PubMed ID: 9716226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon Lambda-3 rs12979860 Variants and Response to Pegylated Interferon in Chronic Hepatitis-C Genotype-3.
    Abbas Z; Yakoob J; Umer MA; Azeem AA; Hamid SS; Jafri W
    J Coll Physicians Surg Pak; 2016 Jun; 26(6):481-5. PubMed ID: 27353984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between histological findings, aminotransferase levels and viral genotype in chronic hepatitis C infection.
    Fecury AA; Almeida MK; Santos KN; Freitas Ada S; Dantas Sde F; Costa CA; Crescente ÂB; Sousa RC; Brito EB; Nassiri R; Lampe E; Martins LC
    Rev Soc Bras Med Trop; 2014; 47(1):90-2. PubMed ID: 24553802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of interferon dose and prediction of response in chronic hepatitis C: Benelux study in 336 patients.
    Brouwer JT; Nevens F; Kleter B; Elewaut A; Adler M; Brenard R; Chamuleau RA; Michielsen PP; Pirotte J; Hautekeete ML; Weber J; Bourgeois N; Hansen BE; Bronkhorst CM; ten Kate FJ; Heijtink RA; Fevery J; Schalm SW
    J Hepatol; 1998 Jun; 28(6):951-9. PubMed ID: 9672169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon retreatment of patients with chronic hepatitis C. A long-term follow-up.
    Spadaro A; Freni MA; Ajello A; Alessi N; Barbaro E; Resta ML; Ferraü O
    Hepatogastroenterology; 1999; 46(30):3229-33. PubMed ID: 10626191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete eradication of hepatitis C virus after interferon treatment for chronic hepatitis C.
    De Mitri MS; Morsica G; Chen CH; Mele L; Baccarini P; Chianese R; Piccinini A; Lazzarin A; Pisi E
    Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):255-61. PubMed ID: 9646218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of alpha-glutathione S-transferase assessment in chronic hepatitis C patients with near normal alanine aminotransferase levels.
    Giannini E; Risso D; Ceppa P; Botta F; Chiarbonello B; Fasoli A; Malfatti F; Romagnoli P; Lantieri PB; Testa R
    Clin Biochem; 2000 Jun; 33(4):297-301. PubMed ID: 10936589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy.
    Marcellin P; Boyer N; Gervais A; Martinot M; Pouteau M; Castelnau C; Kilani A; Areias J; Auperin A; Benhamou JP; Degott C; Erlinger S
    Ann Intern Med; 1997 Nov; 127(10):875-81. PubMed ID: 9382365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.